VICTOR: Vericiguat Global Study in Participants with Chronic Heart Failure and VICTORIA: Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction

30 August 2025 (08:43 - 08:53)
Organised by: Logo
Congress Presentation Part of: HOT LINE 2 Heart Failure with Reduced Ejection Fraction (HFrEF) ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo

Baylor Scott & White Health, Dallas (United States of America)

Access the full session

The Event

Event poster

ESC Congress 2025

30 August 2025 08:43 CET